...
首页> 外文期刊>Journal of Surgical Research: Clinical and Laboratory Investigation >Microsatellite instability status affects gene expression profiles in early onset colorectal cancer patients
【24h】

Microsatellite instability status affects gene expression profiles in early onset colorectal cancer patients

机译:微卫星不稳定性状态影响早发大肠癌患者的基因表达谱

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: The association between microsatellite instability (MSI) status and gene expression profiles in the early onset sporadic colorectal cancer (CRC) has not been clearly established. The aim of this study was to identify the altered gene expression patterns depending on the MSI status of early onset CRC and determine specific biomarkers that could provide novel therapeutic molecular targets in the Turkish population. Materials and methods: MSI markers (BAT25, BAT26, D2S123, D5S346, and D17S250) were investigated in tumors from 36 early onset sporadic CRC patients in whom gene expression profiles were analyzed previously. The relationship between the gene expression profiles depending on MSI status was evaluated. Results: A total of 15 tumors (16.66%) were identified as having MSI and 21 tumors (58.33%) were identified as having microsatellite stability (MSS). CK20 and MAP3K8 upregulation, observed in MSS tumors, was significantly associated with lymph node metastasis, recurrence, and/or distant metastasis and a short median survival (P < 0.05). REG1A upregulation is also correlated with recurrence and/or distant metastasis and a short median survival in patients with MSI tumors (P < 0.05). Conclusions: High expression levels of CK20 and MAP3K8 in MSS tumors and REG1A in MSI tumors correlated with a poor prognosis in CRC patients. Further studies and validations are required; these genes may provide novel therapeutic molecular targets for the development of anticancer drugs related to MSI status for early onset CRC treatment.
机译:背景:早期散发性结直肠癌(CRC)的微卫星不稳定性(MSI)状态与基因表达谱之间的关联尚未明确。这项研究的目的是根据早发CRC的MSI状态鉴定改变的基因表达模式,并确定可以在土耳其人群中提供新型治疗分子靶标的特定生物标记。材料和方法:在来自36位早期发作的散发性CRC患者的肿瘤中,对MSI标记(BAT25,BAT26,D2S123,D5S346和D17S250)进行了研究,这些患者先前已分析了基因表达谱。评估了取决于MSI状态的基因表达谱之间的关系。结果:总共鉴定出具有MSI的15个肿瘤(16.66%)和鉴定为具有微卫星稳定性(MSS)的21个肿瘤(58.33%)。在MSS肿瘤中观察到的CK20和MAP3K8上调与淋巴结转移,复发和/或远处转移以及较短的中位生存期显着相关(P <0.05)。 REG1A上调还与MSI肿瘤患者的复发和/或远处转移以及中位生存期短有关(P <0.05)。结论:MSS肿瘤中CK20和MAP3K8的高表达以及MSI肿瘤中的REG1A的高表达与CRC患者的预后不良有关。需要进一步的研究和验证;这些基因可能为开发与MSI状态相关的抗癌药物提供新的治疗分子靶点,以用于早期CRC治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号